Cue Biopharma, Inc.
NASDAQ:CUE
0.565 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 48.514 | 51.614 | 64.371 | 74.866 | 44.29 | 20.8 | 63.534 | 14.926 | 6.405 |
| Short Term Investments
| 0 | 24.675 | 0 | 10.003 | 15.12 | 18.413 | 0.05 | 0.05 | 0.05 |
| Cash and Short Term Investments
| 48.514 | 76.289 | 64.371 | 84.869 | 44.29 | 39.213 | 63.584 | 14.976 | 6.455 |
| Net Receivables
| 1.698 | 0.057 | 3.143 | 1.417 | 0.755 | 0 | 0.852 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 15.12 | 0 | 0.226 | 0 | 0 |
| Other Current Assets
| 1.242 | 0.841 | 0.955 | 1.241 | 0.86 | 1.347 | 0.403 | 0.162 | 0.051 |
| Total Current Assets
| 51.454 | 77.187 | 68.468 | 87.527 | 61.025 | 40.61 | 65.065 | 15.138 | 6.507 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 7.118 | 10.702 | 11.922 | 8.882 | 7.184 | 2.781 | 1.691 | 1.023 | 0.709 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0.012 | 0 | 0.175 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0.012 | 0 | 0.175 | 0 | 0 |
| Long Term Investments
| 0.151 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | -0.162 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.807 | 3.244 | 2.861 | 2.974 | 3.396 | 1.822 | 0.023 | 0.117 | 0.099 |
| Total Non-Current Assets
| 10.076 | 14.096 | 14.933 | 12.006 | 10.58 | 4.753 | 1.889 | 1.14 | 0.808 |
| Total Assets
| 61.53 | 91.283 | 83.401 | 99.534 | 71.605 | 45.363 | 66.954 | 16.279 | 7.315 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 3.501 | 2.731 | 2.591 | 2.07 | 0.883 | 2.035 | 1.329 | 0.524 | 0.14 |
| Short Term Debt
| 7.331 | 5.263 | 4.932 | 4.777 | 4.448 | 0 | 2.5 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 2.112 | 0 | 0.645 | 6.681 | 4.097 | 2.012 | 0.624 | 0 | 0 |
| Other Current Liabilities
| 4.137 | 3.554 | 4.62 | 2.787 | 2.227 | 2.17 | 0.894 | 0.544 | 0.203 |
| Total Current Liabilities
| 17.081 | 11.549 | 12.788 | 16.316 | 11.655 | 6.217 | 5.347 | 1.068 | 0.342 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 4.202 | 14.052 | 5.121 | 2.369 | 1.348 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 1.938 | 4.018 | 5.175 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -1.938 | -4.018 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.162 | 0 | 0 | 1.938 | 4.018 | 0 | 0 | 0.036 | 0.034 |
| Total Non-Current Liabilities
| 7.364 | 14.052 | 5.121 | 4.306 | 5.366 | 5.175 | 0 | 0.036 | 0.034 |
| Total Liabilities
| 24.445 | 25.601 | 17.909 | 20.622 | 17.021 | 11.392 | 5.347 | 1.104 | 0.376 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.047 | 0.043 | 0.032 | 0.03 | 0.027 | 0.021 | 0.02 | 0.011 | 0.007 |
| Retained Earnings
| -301.19 | -250.457 | -197.446 | -153.285 | -108.5 | -71.801 | -32.821 | -9.587 | -1.929 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.096 | -0 | 0.007 | -0.01 | -0.011 | -0.661 | -0.247 | -0.045 |
| Other Total Stockholders Equity
| 338.228 | 316.192 | 262.906 | 232.159 | 163.068 | 105.763 | 95.069 | 24.998 | 8.905 |
| Total Shareholders Equity
| 37.085 | 65.683 | 65.492 | 78.911 | 54.584 | 33.971 | 61.607 | 15.175 | 6.938 |
| Total Equity
| 37.085 | 65.683 | 65.492 | 78.911 | 54.584 | 33.971 | 61.607 | 15.175 | 6.938 |
| Total Liabilities & Shareholders Equity
| 61.53 | 91.283 | 83.401 | 99.534 | 71.605 | 45.363 | 66.954 | 16.279 | 7.315 |